Rafarma Pharmaceuticals Company Description
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia.
It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules.
The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders.
The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease.
Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012.
The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R.
& D. Biocogency Laboratories Inc. Ltd.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
Contact Details
Address: 49 West 9000 South Sandy, Wyoming 84070 United States | |
| Phone | 801-210-7135 |
| Website | rafarma.si |
Stock Details
| Ticker Symbol | RAFA |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| ISIN Number | US75062C1009 |
| SIC Code | 6799 |
Key Executives
| Name | Position |
|---|---|
| Sergey Brusnitsin J.D., Ph.D. | Chief Financial Officer and Director |
| Anucha Phetpheng | Executive Vice-President for Thai Operations |
| Alexander Ageev Esq. | Secretary, Treasurer and Director |